Previous Page  34 / 60 Next Page
Information
Show Menu
Previous Page 34 / 60 Next Page
Page Background

Notes:

Page 34

conferenceseries

.com

Volume 09

Journal of Gastrointestinal & Digestive System

ISSN: 2161-069X

Gastro Congress 2019

July 08-09, 2019

July 08-09, 2019 | Zurich, Switzerland

14

th

Euro-Global Gastroenterology Conference

Nitric oxide donor, S-nitrosoglutathione, to maintain intestinal barrier integrity: Potential therapeutic

candidate for prevention of inflammation recurrences

Romain Schmitt

1

, Haiyan Yu

1

, Pierre Leroy

1

, Franck Hansmannel

1,2

, Igor Clarot

1

, Isabelle Lartaud

1

and

Anne Sapin-minet

1

1

University of Lorraine, France

2

NGERE Inserm U1256 Lab, France

N

itric oxide (NO) is known to play a pivotal role to maintain the intestinal barrier integrity, such as regulation

of oxidative stress, healing, mucus secretion, immune system regulation, etc. S-nitrosoglutathione (GSNO), a

nitric oxide donor is naturally secreted by enteric glial cells after stimulation of the vagus nerve. GSNO is known

to prevent inflammatory events and to preserve intestinal barrier integrity. We have highlight in a Ussing chamber

model that there is a concentration-dependant effect of NO on rat ileon intestinal permeability: A low concentration

of GSNO (0.1 µm) significantly decreases the permeability of sodium fluorescein after two hours when compared to

high concentrations (100 µm). This effect is not observed in the presence of glutathion equivalent concentrations.

Moreover, GSNO degradation and absorption on isolated rat intestine were studied and we found that an enzymatic

activity of gamma-glutamyl-transpeptidase expressed on intestinal epithelioma (and also by microbiota), is involved

in GSNO intestinal permeability. Also, the inhibition of endogenous secretion of NO by using N-nitro-L-arginine

methyl ester (NO synthases inhibitor) showed us that NO observed effect in intestinal permeability comes from

exogenous supply with GSNO. From these results, GSNO could be proposed as an innovative prophylactic agent, in

order to prevent relapses of inflammation for inflammatory bowel diseases patient in clinical remission.

Recent Publications

1. Cheadle G A,

et al.,

(2013) Enteric glia cells attenuate cytomix-induced intestinal epithelial barrier breakdown.

PloS one, 8(7):e69042.

2. Savidge T C,

et al.,

(2007) Enteric glia regulate intestinal barrier function and inflammation via release of

S-nitrosoglutathione. Gastroenterology 132(4):1344-1358.

3. Hanigan M H and Frierson H F (1996) Immunohistochemical detection of gamma-glutamyl transpeptidase in

normal human tissue. J Histochem Cytochem 44(10):1101-1108.

Biography

Romain Schmitt is pursuing his PhD and is currently working at the NGERE Inserm U1256 Lab, France. He has already published few papers with his colleagues

and is currently working on many papers that will be published in the upcoming year.

romain.schmitt@univ-lorraine.fr

Romain Schmitt et al., J Gastrointest Dig Syst 2019, Volume 09